Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Rising Burden of Psychiatric and Behavioral Disorders and Their Adverse Impact on Health Care Expenditure in Hospitalized Pediatric Patients with Inflammatory Bowel Disease

  • Aravind Thavamani (Division of Pediatric Gastroenterology, Hepatology and Nutrition, UH Rainbow Babies and Children's Hospital, Case Western Reserve University School of Medicine) ;
  • Jasmine Khatana (Department of Pediatrics, Metro Health Medical Center, Case Western Reserve University School of Medicine) ;
  • Krishna Kishore Umapathi (Division of Pediatric Cardiology, Rush University Medical Center) ;
  • Senthilkumar Sankararaman (Division of Pediatric Gastroenterology, Hepatology and Nutrition, UH Rainbow Babies and Children's Hospital, Case Western Reserve University School of Medicine)
  • Received : 2021.09.10
  • Accepted : 2022.10.07
  • Published : 2023.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The incidence and prevalence of inflammatory bowel disease (IBD) are increasing along with an increasing number of patients with comorbid conditions like psychiatric and behavioral disorders, which are independent predictors of quality of life. Methods: Non-overlapping years (2003-2016) of National Inpatient Sample and Kids Inpatient Database were analyzed to include all IBD-related hospitalizations of patients less than 21 years of age. Patients were analyzed for a concomitant diagnosis of psychiatric/ behavioral disorders and were compared with IBD patients without psychiatric/behavioral disorder diagnoses for outcome variables: IBD severity, length of stay and inflation-adjusted hospitalization charges. Results: Total of 161,294 IBD-related hospitalizations were analyzed and the overall prevalence rate of any psychiatric and behavioral disorders was 15.7%. Prevalence rate increased from 11.3% (2003) to 20.6% (2016), p<0.001. Depression, substance use, and anxiety were the predominant psychiatric disorders. Regression analysis showed patients with severe IBD (odds ratio [OR], 1.57; confidence interval [CI], 1.47-1.67; p<0.001) and intermediate IBD (OR, 1.14; CI, 1.10-1.28, p<0.001) had increased risk of associated psychiatric and behavioral disorders than patients with a low severity IBD. Multivariate analysis showed that psychiatric and behavioral disorders had 1.17 (CI, 1.07-1.28; p<0.001) mean additional days of hospitalization and incurred additional $8473 (CI, 7,520-9,425; p<0.001) of mean hospitalization charges, independent of IBD severity. Conclusion: Prevalence of psychiatric and behavioral disorders in hospitalized pediatric IBD patients has been significantly increasing over the last two decades, and these disorders were independently associated with prolonged hospital stay, and higher total hospitalization charges.

Keywords

References

  1. Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2017;390:2769-78. Erratum in: Lancet 2020;396:e56. 
  2. Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A, et al. Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology 2019;156:1345-53.e4.  https://doi.org/10.1053/j.gastro.2019.01.002
  3. Thavamani A, Umapathi KK, Khatana J, Gulati R. Burden of psychiatric disorders among pediatric and young adults with inflammatory bowel disease: a population-based analysis. Pediatr Gastroenterol Hepatol Nutr 2019;22:527-35.  https://doi.org/10.5223/pghn.2019.22.6.527
  4. Butwicka A, Olen O, Larsson H, Halfvarson J, Almqvist C, Lichtenstein P, et al. Association of childhoodonset inflammatory bowel disease with risk of psychiatric disorders and suicide attempt. JAMA Pediatr 2019;173:969-78.  https://doi.org/10.1001/jamapediatrics.2019.2662
  5. Martone G. The inflammation hypothesis and mental illness. J Clin Psychiatr Neurosci 2019;2:3-12.
  6. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001;58:445-52.  https://doi.org/10.1001/archpsyc.58.5.445
  7. Rao U. Biomarkers in pediatric depression. Depress Anxiety 2013;30:787-91.  https://doi.org/10.1002/da.22171
  8. Engelmann G, Erhard D, Petersen M, Parzer P, Schlarb AA, Resch F, et al. Health-related quality of life in adolescents with inflammatory bowel disease depends on disease activity and psychiatric comorbidity. Child Psychiatry Hum Dev 2015;46:300-7.  https://doi.org/10.1007/s10578-014-0471-5
  9. Guthrie E, Jackson J, Shaffer J, Thompson D, Tomenson B, Creed F. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol 2002;97:1994-9.  https://doi.org/10.1016/S0002-9270(02)04198-9
  10. Rufo PA, Denson LA, Sylvester FA, Szigethy E, Sathya P, Lu Y, et al. Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations. J Pediatr Gastroenterol Nutr 2012;55:93-108.  https://doi.org/10.1097/MPG.0b013e31825959b8
  11. Mackner LM, Greenley RN, Szigethy E, Herzer M, Deer K, Hommel KA. Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2013;56:449-58.  https://doi.org/10.1097/MPG.0b013e3182841263
  12. Healthcare Cost and Utilization Project. Description of data elements [Internet]. Rockville (MD): Agency for Healthcare Research and Quality; 2022 [cited 2022 Jul 6]. Available from: https://www.hcup-us.ahrq. gov/db/nation/nis/nisdde.jsp
  13. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. A novel risk score to stratify severity of Crohn's disease hospitalizations. Am J Gastroenterol 2010;105:1799-807.  https://doi.org/10.1038/ajg.2010.105
  14. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. Simple score to identify colectomy risk in ulcerative colitis hospitalizations. Inflamm Bowel Dis 2010;16:1532-40.  https://doi.org/10.1002/ibd.21225
  15. Szigethy E, Murphy SM, Ehrlich OG, Engel-Nitz NM, Heller CA, Henrichsen K, et al. Mental health costs of inflammatory bowel diseases. Inflamm Bowel Dis 2021;27:40-8.  https://doi.org/10.1093/ibd/izaa030
  16. Szigethy E, Levy-Warren A, Whitton S, Bousvaros A, Gauvreau K, Leichtner AM, et al. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr 2004;39:395-403.  https://doi.org/10.1002/j.1536-4801.2004.tb00873.x
  17. Narula N, Pinto-Sanchez MI, Calo NC, Ford AC, Bercik P, Reinisch W, et al. Anxiety but not depression predicts poor outcomes in inflammatory bowel disease. Inflamm Bowel Dis 2019;25:1255-61.  https://doi.org/10.1093/ibd/izy385
  18. Gray WN, Denson LA, Baldassano RN, Hommel KA. Treatment adherence in adolescents with inflammatory bowel disease: the collective impact of barriers to adherence and anxiety/depressive symptoms. J Pediatr Psychol 2012;37:282-91.  https://doi.org/10.1093/jpepsy/jsr092
  19. Lee EJ, Rami A, Sebastian L, Jim M, Bradley W, Humberto S. Psychiatric conditions are associated with medical noncompliance and worsening disease course in IBD patient population. Am J Gastroenterol 2018;113(Supple 1):S20. CROSSREF
  20. Patel PV, Pantell MS, Heyman MB, Verstraete S. Depression predicts prolonged length of hospital stay in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2019;69:570-4.  https://doi.org/10.1097/MPG.0000000000002426
  21. Ali H, Pamarthy R, Bolick NL, Lambert K, Naseer M. Relation between inflammatory bowel disease, depression, and inpatient outcomes in the United States. Proc (Bayl Univ Med Cent) 2022;35:278-83.  https://doi.org/10.1080/08998280.2022.2028344
  22. Marrie RA, Walker JR, Graff LA, Lix LM, Bolton JM, Nugent Z, et al. Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease. J Psychosom Res 2016;89:107-13.  https://doi.org/10.1016/j.jpsychores.2016.08.014
  23. Bernstein CN, Hitchon CA, Walld R, Bolton JM, Sareen J, Walker JR, et al. Increased burden of psychiatric disorders in inflammatory bowel disease. Inflamm Bowel Dis 2019;25:360-8.   https://doi.org/10.1093/ibd/izy235